{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:30:21Z","timestamp":1792251021507,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.bone.2014.04.012","type":"journal-article","created":{"date-parts":[[2014,4,18]],"date-time":"2014-04-18T14:33:00Z","timestamp":1397831580000},"page":"183-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["A large amount of microdamages in the cortical bone around fracture site in a patient of atypical femoral fracture after long-term bisphosphonate therapy"],"prefix":"10.1016","volume":"64","author":[{"given":"Ken","family":"Iwata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Mashiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Hitora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2014.04.012_bb0005","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.1998.16.6.2038","article-title":"Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate","volume":"16","author":"Hortobagyi","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bone.2014.04.012_bb0010","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/cncr.20308","article-title":"Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial","volume":"100","author":"Rosen","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.bone.2014.04.012_bb0015","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1200\/JCO.2005.05.116","article-title":"Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial","volume":"23","author":"Kohno","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bone.2014.04.012_bb0020","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.04.012_bb0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1302\/0301-620X.89B3.18146","article-title":"Subtrochanteric insufficiency fractures in patients on alendronate therapy","volume":"89-B","author":"Goh","year":"2007","journal-title":"J Bone Joint Surg [Br]"},{"key":"10.1016\/j.bone.2014.04.012_bb0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","article-title":"Low-energy femoral shaft fractures associated with alendronate use","volume":"22","author":"Neviaser","year":"2008","journal-title":"J Orthop Trauma"},{"key":"10.1016\/j.bone.2014.04.012_bb0035","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","article-title":"An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?","volume":"39","author":"Kwek","year":"2008","journal-title":"Injury"},{"key":"10.1016\/j.bone.2014.04.012_bb0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00223-009-9263-5","article-title":"Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series","volume":"85","author":"Armamento-Villareal","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2014.04.012_bb0045","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Mineral Res"},{"key":"10.1016\/j.bone.2014.04.012_bb0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00003086-199011000-00047","article-title":"Validity of the bulk-staining technique to separate artifactual from in vivo bone microdamage","volume":"260","author":"Burr","year":"1990","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.bone.2014.04.012_bb0055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S8756-3282(97)00004-5","article-title":"Microdamage of human cortical bone: incidence and morphology in long bones","volume":"20","author":"Norman","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.012_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jbmr.5650030203","article-title":"Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females","volume":"3","author":"Recker","year":"1988","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.012_bb0065","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI119668","article-title":"Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis","volume":"100","author":"Chavassieux","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2014.04.012_bb0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S8756-3282(00)00434-8","article-title":"Influence of nonenzymatic glycation on biomechanical properties of cortical bone","volume":"28","author":"Vashishth","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.012_bb0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00198-007-0533-7","article-title":"Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra","volume":"19","author":"Allen","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2014.04.012_bb0080","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00198-008-0585-3","article-title":"Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs","volume":"19","author":"Saito","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2014.04.012_bb0085","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00198-008-0754-4","article-title":"Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate","volume":"20","author":"Tang","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2014.04.012_bb0090","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2009.09.003","article-title":"Non-enzymatic glycation alters microdamage formation in human cancellous bone","volume":"46","author":"Tang","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.012_bb0095","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","article-title":"Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib","volume":"15","author":"Mashiba","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.012_bb0100","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","article-title":"Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles","volume":"28","author":"Mashiba","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.012_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2013.01.016","article-title":"Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys","volume":"54","author":"Yamagami","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.012_bb0110","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bone.2014.04.012_bb0115","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1056\/NEJMc0910389","article-title":"Atypical femoral fractures and bisphosphonate use","volume":"362","author":"Girgis","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2014.04.012_bb0120","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1359\/jbmr.090408","article-title":"Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: clues to the mechanism of increased bone fragility","volume":"24","author":"Somford","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.012_bb0125","first-page":"1736","article-title":"Atypical fractures of the femur and bisphosphonate therapy: a systematic review of case\/case series studies","volume":"24","author":"Guisti","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.04.012_bb0130","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1359\/jbmr.070505","article-title":"Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women","volume":"22","author":"Ivaska","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.04.012_bb0135","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0021-9290(97)00029-8","article-title":"Crack growth resistance in cortical bone: concept of microcrack toughening","volume":"30","author":"Vashishth","year":"1997","journal-title":"J Biomech"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214001471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214001471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T17:26:49Z","timestamp":1565371609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328214001471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":27,"alternative-id":["S8756328214001471"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2014.04.012","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A large amount of microdamages in the cortical bone around fracture site in a patient of atypical femoral fracture after long-term bisphosphonate therapy","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2014.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}